Skip to main content

Table 1 Patient characteristics for all 98 UC samples included in the study

From: Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma

Patient characteristics    Subgroup 1 Subgroup 2 Subgroup 3 Subgroup 4
   Total N N N N
Samples N 98 18 21 24 35
Gender Male 69 12 16 19 22
  Female 29 6 5 5 13
WHO 1999 Stage Ta 45 16 14 5 10
  T1 25 2 5 9 9
  MI 27 0 1 10 16
  Tx 1 0 1 0 0
WHO 1999 Grade Grade 1 19 11 5 1 2
  Grade 2 32 7 11 4 10
  Grade 3 47 0 5 19 23
TP53 mutation Mutation 29 0 4 11 14
  Wild type 69 18 17 13 21
FGFR3 mutation Mutation 34 12 11 1 10
  Wild type 64 6 10 23 25
Lund subtype Urobasal A 44 18 15 2 9
  Urobasal B 12 0 5 2 5
  Genom Unst 29 0 0 17 12
  SCC-like 13 0 1 3 9
Lauss epitype A 17 9 6 0 2
  B 9 1 1 0 7
  C 17 0 1 11 5
  D 7 0 1 0 6
  NAa 48 8 12 13 15
Age (years) Median 71.7 68.5 70.3 70.6 75.4
  Range (43.5-94.8) (43.9-84.3) (49.7-93.0) (59.0-94.8) (43.5-93.5)
  1. aSamples not included in the Lauss et al. [11] study.